Based on the findings in this study, TWIST1 showed a risk factor increasing the mortality in HNSCC, particularly in male patients, whereas TWIST2 exhibited a protective role in decreasing the mortality in HNSCC, particularly in non-smoker patients. Here, TWIST1 is linked to head and neck squamous cell carcinoma.